32 results on '"Castro, Rui"'
Search Results
2. OS-042-YI Metabolic reprogramming induced by pravastatin prevents polycystic liver disease progression improving mitochondrial bioenergetics in cystic cholangiocytes
3. The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH
4. Long-term cellular immune response to COVID-19 vaccination in patients with chronic liver disease
5. Role of TGR5 in fat-to-liver communication during NAFLD
6. Presence of cirrhosis in chronic liver disease patients associates with a lower immune response to COVID-19 vaccines-a multicenter european study
7. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models
8. SAT-554-YI Cellular immunity changes induced by COVID-19 vaccines in patients with chronic liver disease
9. WED-404 - The E2F2-miR34a-5p axis is involved in the biliary metabolism dysregulation in NASH
10. WED-397 - Role of TGR5 in fat-to-liver communication during NAFLD
11. WED-390 - Long-term cellular immune response to COVID-19 vaccination in patients with chronic liver disease
12. Serum metabolic biomarkers for the differential diagnosis of distal cholangiocarcinoma and pancreas ductal adenocarcinoma
13. The role of RIPK3 in non-alcoholic fatty liver disease: a multi-omics perspective
14. mIR-21 is increased in patients with NASH-associated HCC and contributes to hepatocarcinogenesis in mice with NAFLD
15. Administration of lactobacillus alleviates experimental NASH by reducing miR-21 in the liver
16. Hepatic RIPK3 signalling differentially modulates lipid metabolism and inflammation in non-alcoholic fatty liver disease
17. Composite targeting of nuclear receptors protects against diet-induced NAFLD
18. A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid
19. SAT-255-Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials
20. FRI-294-Mitochondrial GNMT-complex II is recovered by miR-873-5p targeting in NAFLD
21. PS-160-miRNA-21 signals through a gut-liver axis to regulate experimental cholestasis
22. FRI-306-RIP3 deficiency restores mitochondrial bioenergetics and function in experimental NAFLD
23. FRI-278-RIP3-dependent signalling exerts divergent effects on liver steatosis and carcinogenesis in experimental non-alcholic fatty liver disease
24. PS-003-Activation of the miR-34a/SIRT1:AMPK axis contributes for insulin resistance and mitochondrial dysfunction in the NAFLD muscle
25. Towards a definite mouse model of NAFLD
26. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease
27. SAT054 - mIR-21 is increased in patients with NASH-associated HCC and contributes to hepatocarcinogenesis in mice with NAFLD.
28. SAT267 - Serum metabolic biomarkers for the differential diagnosis of distal cholangiocarcinoma and pancreas ductal adenocarcinoma.
29. SAT045 - The role of RIPK3 in non-alcoholic fatty liver disease: a multi-omics perspective.
30. SAT041 - Hepatic RIPK3 signalling differentially modulates lipid metabolism and inflammation in non-alcoholic fatty liver disease.
31. FRI121 - Composite targeting of nuclear receptors protects against diet-induced NAFLD.
32. THU189 - Administration of lactobacillus alleviates experimental NASH by reducing miR-21 in the liver.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.